{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T00:04:59Z","timestamp":1754093099271,"version":"3.41.2"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,31]]},"DOI":"10.7759\/cureus.89181","type":"journal-article","created":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T05:45:59Z","timestamp":1754027159000},"source":"Crossref","is-referenced-by-count":0,"title":["Late Administration of Remdesivir, Guided by Antigen Test Results, in a Patient Experiencing Difficulty Weaning From the Ventilator Due to Severe COVID-19 Pneumonia"],"prefix":"10.7759","author":[{"given":"Keisuke","family":"Mataichi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuo","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.7326\/ANNALS-24-00464","article-title":"National Institutes of Health COVID-19 treatment guidelines panel: perspectives and lessons learned","volume":"177","author":"Gulick RM","year":"2024","unstructured":"Gulick RM, Pau AK, Daar E, et al.. National Institutes of Health COVID-19 treatment guidelines panel: perspectives and lessons learned. Ann Intern Med. 2024, 177:1547-57. 10.7326\/ANNALS-24-00464","journal-title":"Ann Intern Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000004899","article-title":"Surviving Sepsis Campaign guidelines on the management of adults with coronavirus disease 2019 (COVID-19) in the ICU: first update","volume":"49","author":"Alhazzani W","year":"2021","unstructured":"Alhazzani W, Evans L, Alshamsi F, et al.. Surviving Sepsis Campaign guidelines on the management of adults with coronavirus disease 2019 (COVID-19) in the ICU: first update. Crit Care Med. 2021, 49:e219-34. 10.1097\/CCM.0000000000004899","journal-title":"Crit Care Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-020-0311-8","article-title":"The trinity of COVID-19: immunity, inflammation and intervention","volume":"20","author":"Tay MZ","year":"2020","unstructured":"Tay MZ, Poh CM, R\u00e9nia L, MacAry PA, Ng LF. The trinity of COVID-19: immunity, inflammation and intervention. Nat Rev Immunol. 2020, 20:363-74. 10.1038\/s41577-020-0311-8","journal-title":"Nat Rev Immunol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2021436","article-title":"Dexamethasone in hospitalized patients with Covid-19","volume":"384","author":"Horby P","year":"2021","unstructured":"Horby P, Lim WS, Emberson JR, et al.. Dexamethasone in hospitalized patients with Covid-19. N Engl J Med. 2021, 384:693-704. 10.1056\/NEJMoa2021436","journal-title":"N Engl J Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2007764","article-title":"Remdesivir for the treatment of Covid-19 - final report","volume":"383","author":"Beigel JH","year":"2020","unstructured":"Beigel JH, Tomashek KM, Dodd LE, et al.. Remdesivir for the treatment of Covid-19 - final report. N Engl J Med. 2020, 383:1813-26. 10.1056\/NEJMoa2007764","journal-title":"N Engl J Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD014962.pub2","article-title":"Remdesivir for the treatment of COVID-19","volume":"1","author":"Grundeis F","year":"2023","unstructured":"Grundeis F, Ansems K, Dahms K, et al.. Remdesivir for the treatment of COVID-19. Cochrane Database Syst Rev. 2023, 1:CD014962. 10.1002\/14651858.CD014962.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2665-2","article-title":"Structures and distributions of SARS-CoV-2 spike proteins on intact virions","volume":"588","author":"Ke Z","year":"2020","unstructured":"Ke Z, Oton J, Qu K, et al.. Structures and distributions of SARS-CoV-2 spike proteins on intact virions. Nature. 2020, 588:498-502. 10.1038\/s41586-020-2665-2","journal-title":"Nature"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2020.165878","article-title":"Insights into SARS-CoV-2 genome, structure, evolution, pathogenesis and therapies: structural genomics approach","volume":"1866","author":"Naqvi AA","year":"2020","unstructured":"Naqvi AA, Fatima K, Mohammad T, et al.. Insights into SARS-CoV-2 genome, structure, evolution, pathogenesis and therapies: structural genomics approach. Biochim Biophys Acta Mol Basis Dis. 2020, 1866:165878. 10.1016\/j.bbadis.2020.165878","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s10930-020-09901-4","article-title":"The proteins of severe acute respiratory syndrome coronavirus-2 (SARS CoV-2 or n-COV19), the cause of COVID-19","volume":"39","author":"Yoshimoto FK","year":"2020","unstructured":"Yoshimoto FK. The proteins of severe acute respiratory syndrome coronavirus-2 (SARS CoV-2 or n-COV19), the cause of COVID-19. Protein J. 2020, 39:198-216. 10.1007\/s10930-020-09901-4","journal-title":"Protein J"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.27316","article-title":"Immunogenicity after two doses of inactivated virus vaccine in healthcare workers with and without previous COVID-19 infection: prospective observational study","volume":"94","author":"Yal\u00e7\u0131n TY","year":"2022","unstructured":"Yal\u00e7\u0131n TY, Top\u00e7u DI, Do\u011fan \u00d6, et al.. Immunogenicity after two doses of inactivated virus vaccine in healthcare workers with and without previous COVID-19 infection: prospective observational study. J Med Virol. 2022, 94:279-86. 10.1002\/jmv.27316","journal-title":"J Med Virol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1093\/clinchem\/hvaa213","article-title":"Ultra-sensitive serial profiling of SARS-CoV-2 antigens and antibodies in plasma to understand disease progression in COVID-19 patients with severe disease","volume":"66","author":"Ogata AF","year":"2020","unstructured":"Ogata AF, Maley AM, Wu C, et al.. Ultra-sensitive serial profiling of SARS-CoV-2 antigens and antibodies in plasma to understand disease progression in COVID-19 patients with severe disease. Clin Chem. 2020, 66:1562-72. 10.1093\/clinchem\/hvaa213","journal-title":"Clin Chem"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-021-01220-0","article-title":"Plitidepsin as a successful rescue treatment for prolonged viral SARS-CoV-2 replication in a patient with previous anti-CD20 monoclonal antibody-mediated B cell depletion and chronic lymphocytic leukemia","volume":"15","author":"Guisado-Vasco P","year":"2022","unstructured":"Guisado-Vasco P, Carral\u00f3n-Gonz\u00e1lez MM, Aguareles-Gorines J, et al.. Plitidepsin as a successful rescue treatment for prolonged viral SARS-CoV-2 replication in a patient with previous anti-CD20 monoclonal antibody-mediated B cell depletion and chronic lymphocytic leukemia. J Hematol Oncol. 2022, 15:4. 10.1186\/s13045-021-01220-0","journal-title":"J Hematol Oncol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-7158-9","article-title":"SARS-CoV-2 viral load is linked to remdesivir efficacy in severe COVID-19 admitted to intensive care","volume":"14","author":"Balik M","year":"2024","unstructured":"Balik M, Waldauf P, Jurisinova I, et al.. SARS-CoV-2 viral load is linked to remdesivir efficacy in severe COVID-19 admitted to intensive care. Sci Rep. 2024, 14:20825. 10.1038\/s41598-024-7158-9","journal-title":"Sci Rep"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/390441-late-administration-of-remdesivir-guided-by-antigen-test-results-in-a-patient-experiencing-difficulty-weaning-from-the-ventilator-due-to-severe-covid-19-pneumonia","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T05:46:02Z","timestamp":1754027162000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/390441-late-administration-of-remdesivir-guided-by-antigen-test-results-in-a-patient-experiencing-difficulty-weaning-from-the-ventilator-due-to-severe-covid-19-pneumonia"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,31]]},"references-count":13,"URL":"https:\/\/doi.org\/10.7759\/cureus.89181","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7,31]]}}}